Skip to main content
OpenTrials
Completed

NCT Number: NCT07418203

Knowledge of 18-19 Years Old About Papillomavirus and HPV Vaccination

Today, cancers associated with papillomavirus infection affect 6,300 new people each year in France, men and women combined. The papillomavirus vaccine is currently the only vaccine that protects against HPV-associated cancers. However, in its report on vaccination coverage for 2024, Santé Publique France reveals that 41.5% and 37.4% of the 18- and 19-year-old French population respectively have a complete vaccination schedule.

Information, education and communication about HPV are essential to enable the entire population to make informed and responsible decisions about HPV.

Increasing information and immunization coverage for papillomavirus is part of the government's ambitious health plans with the national sexual health strategy and college vaccination campaign.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Human Papillomavirus

Age range

18 year–19 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ufr Medecine Urca

Reims, 51100, France

About this study

The main objective is to describe knowledge of girls and boys aged 18-19 about papillomavirus and HPV vaccination

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Boys and girls 18 to 19 years of age Vaccinated or not against HPV Sexually active or not Agreeing to take part in the study

Exclusion criteria

Minors Age 20 and over Protected by law (guardianship, curatorship, safeguard of justice) Not wishing to answer the questionnaire

Treatment and study plan

Data Collection

Other

Data collection

Primary outcomes

  1. Knowledge about HPV and anti-HPV vaccination

    Time frame: Day 0

    Knowledge about HPV and anti-HPV vaccination will be assessed by a questionnaire developed by a team of midwives and methodologists. Questions will address:

    Knowledge about HPV infection Knowledge of prevention measures Knowledge about HPV vaccination

Sponsors and collaborators

Lead sponsor

Université de Reims Champagne-Ardenne

Other

Registry information

Acronym: CO-HPV

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Feb 18, 2026
Registry last updated
Feb 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.